yingweiwo

Beta Amyloid

Beta Amyloid

Beta Amyloid related products

Structure Cat No. Product Name CAS No. Product Description
4-Sulfocalix[4]arene V111853 4-Sulfocalix[4]arene 112269-92-8 4-Sulfocalix[4]arene (p-sulfonocalix[n]arene) is an amyloid β42 (amyloid β42) binder with a Kd value of 5.39 M.
AAKLVFF V113880 AAKLVFF 1038400-67-7 AAKLVFF is an oligopeptide that can self-assemble into nanotubes.
AChE-IN-59 V87778 AChE-IN-59 2957916-86-6 AChE-IN-59 (compounds 3b) is an inhibitor of AChE with an IC50 value of 0.05 µM.
AChE/BChE-IN-12 V79262 AChE/BChE-IN-12 AChE/BChE-IN-12 (compound 10b), a 3,5-dimethoxy analog, is a potent inhibitor of AChE, BChE and beta-secretase-1 (BACE-1) with IC50s respectively are 2.57, 3.26 and 10.65 μM.
Amyloid β-Protein (3-42) TFA V128798 Amyloid β-Protein (3-42) TFA Amyloid β-Protein (3-42) TFA is a precursor of Pyr peptide.
Amyloid-β-IN-1 V128799 Amyloid-β-IN-1 Amyloid-β-IN-1 is a synthetic peptide containing the hydrophobic C-terminal region “VVIA-NH2” of Aβ42 and its reverse sequence “AIVV-NH2”, and is an Aβ inhibitor.
Aβ aggregation-IN-4 V111796 Aβ aggregation-IN-4 603113-07-1 The Aβ aggregation inhibitor IN-4 can alleviate the neurotoxicity of β-amyloid (Aβ) and significantly reduce the level of Aβ oligomer complexes (Aβ-OCs).
Aβ-IN-6 V78525 Aβ-IN-6 Aβ-IN-6 reduces proinflammatory cytokine release from microglia.
Cbz-Gly-Pro-Ala-O-cinnamyl V88215 Cbz-Gly-Pro-Ala-O-cinnamyl Cbz-Gly-Pro-Ala-O-cinnamyl (compound 25) is a small peptide targeting BACE-1 and AChE with IC50 values of 0.02 μM and 1 μM, respectively.
Coumarinic acid V71432 Coumarinic acid 495-79-4 Coumarinic acid is a brain-penetrating inhibitor of AChE and β-amyloid.
Donanemab (Mouse IgG2a) V134181 Donanemab (Mouse IgG2a) Donanemab (Mouse IgG2a) is a mouse-derived IgG2 monoclonal antibody used in research on Alzheimer's disease.
Glutaminyl Cyclase Inhibitor 6 V87776 Glutaminyl Cyclase Inhibitor 6 Glutaminyl Cyclase Inhibitor 6 (compound BI-43) is a secretory glutaminyl cyclase (sQC) and golgi-resident glutaminyl cyclase (gQC) inhibitor with IC50 values of 0.012 and 0.040 µM, respectively.
Glycerophosphorylethanolamine sodium V136771 Glycerophosphorylethanolamine sodium 883288-78-6 Glycerophosphorylethanolamine sodium is an active phosphodiester metabolite of phosphatidylethanolamine.
hAChE/hBACE-1-IN-2 V79406 hAChE/hBACE-1-IN-2 hAChE/hBACE-1-IN-2 is a potent, orally bioactive, BBB (blood-brain barrier) permeable (penetrable) triple inhibitor of hAChE/hBChE/hBACE-1 with IC50s of 0.113 μM, 1.48 μM and 0.38 μM respectively.
LPYFD-NH2 TFA V80619 LPYFD-NH2 TFA LPYFD-NH2 TFA is a pentapeptide that can inhibit the aggregation of Aβ(1-42).
Methyl tridecanoate V71441 Methyl tridecanoate 1731-88-0 Methyl tridecanoate moderately inhibits β-amyloid protein (β-amyloid) aggregation.
MG-H1 V109021 MG-H1 149204-50-2 MG-H1 is a ligand for the receptor for advanced glycation end products (RAGE) with a dissociation constant (Kd) of 4.12 nM.
Mivelsiran sodium scrambled negative control V140013 Mivelsiran sodium scrambled negative control The Mivelsiran sodium scrambled negative control is a negative control for Mivelsiran sodium with a scrambled sequence.
p-HTAA V71428 p-HTAA 1175142-38-7 p-HTAA is a pentameric hydrothiopheneacetic acid.
PHF6 TFA V87773 PHF6 TFA PHF6 (VQIVYK) TFA is a self-assembly sequence that initiates aggregation of full-length tau and is mapped to the third microtubule-binding repeat region of tau.
Contact Us